Profile | GDS4284 / 209522_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 479.328 | 63 |
GSM687648 | Patient 402 control | 632.001 | 67 |
GSM687653 | Patient 403 control | 425.869 | 62 |
GSM687658 | Patient 404 control | 285.428 | 55 |
GSM687663 | Patient 411 control | 534.693 | 64 |
GSM687668 | Patient 422 control | 437.187 | 62 |
GSM687673 | Patient 424 control | 715.12 | 69 |
GSM687678 | Patient 425 control | 494.378 | 62 |
GSM687683 | Patient 427 control | 832.473 | 71 |
GSM687688 | Patient 428 control | 627.52 | 67 |
GSM687695 | Patient 441 control | 1764.63 | 84 |
GSM687699 | Patient 443 control | 420.561 | 60 |
GSM687704 | Patient 444 control | 346.753 | 58 |
GSM687707 | Patient 448 control | 456.455 | 62 |
GSM687712 | Patient 449 control | 380.998 | 59 |
GSM687719 | Patient 450 control | 412.522 | 59 |
GSM687724 | Patient 451 control | 535.327 | 65 |
GSM687728 | Patient 452 control | 609.049 | 67 |
GSM687646 | Patient 401 treated 24h | 609.479 | 66 |
GSM687649 | Patient 402 treated 24h | 502.065 | 64 |
GSM687665 | Patient 411 treated 24h | 635.579 | 67 |
GSM687651 | Patient 402 treated 4 weeks | 683.978 | 68 |
GSM687667 | Patient 411 treated 4 weeks | 574.07 | 65 |
GSM687670 | Patient 422 treated 24h | 449.851 | 61 |
GSM687671 | Patient 422 treated 4 weeks | 475.601 | 63 |
GSM687654 | Patient 403 treated 24h | 532.625 | 65 |
GSM687675 | Patient 424 treated 24h | 509.231 | 63 |
GSM687685 | Patient 427 treated 24h | 784.227 | 70 |
GSM687656 | Patient 403 treated 4 weeks | 463.413 | 63 |
GSM687677 | Patient 424 treated 4 weeks | 623.167 | 67 |
GSM687687 | Patient 427 treated 4 weeks | 519.444 | 64 |
GSM687692 | Patient 428 treated 4h | 365.084 | 59 |
GSM687716 | Patient 449 treated 4h | 373.268 | 60 |
GSM687722 | Patient 450 treated 4h | 411.717 | 59 |
GSM687680 | Patient 425 treated 24h | 442.985 | 61 |
GSM687690 | Patient 428 treated 24h | 308.369 | 57 |
GSM687700 | Patient 443 treated 24h | 1279.59 | 78 |
GSM687705 | Patient 444 treated 24h | 424.617 | 62 |
GSM687714 | Patient 449 treated 24h | 429.587 | 62 |
GSM687721 | Patient 450 treated 24h | 524.577 | 63 |
GSM687682 | Patient 425 treated 4 weeks | 527.184 | 65 |
GSM687694 | Patient 428 treated 4 weeks | 514.932 | 64 |
GSM687702 | Patient 443 treated 4 weeks | 593.482 | 65 |
GSM687718 | Patient 449 treated 4 weeks | 569.504 | 66 |
GSM687723 | Patient 450 treated 4 weeks | 390.796 | 59 |
GSM687661 | Patient 404 treated 4h | 401.849 | 60 |
GSM687710 | Patient 448 treated 4h | 239.262 | 52 |
GSM687726 | Patient 451 treated 4h | 476.261 | 62 |
GSM687730 | Patient 452 treated 4h | 1714.53 | 83 |
GSM687660 | Patient 404 treated 24h | 400.561 | 60 |
GSM687697 | Patient 441 treated 24h | 806.117 | 71 |
GSM687709 | Patient 448 treated 24h | 333.92 | 57 |
GSM687725 | Patient 451 treated 24h | 652.331 | 67 |
GSM687729 | Patient 452 treated 24h | 745.75 | 71 |
GSM687727 | Patient 451 treated 4 weeks | 773.941 | 70 |
GSM687731 | Patient 452 treated 4 weeks | 502.633 | 63 |